TDOC Teladoc Health Inc.

Teladoc Health to Participate in Upcoming Investor Conference

Teladoc Health to Participate in Upcoming Investor Conference

NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, announced today that Chuck Divita, chief executive officer, will participate in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 12, 2026, at 3:45 p.m. PT (6:45 p.m. ET). A live audio webcast and replay of the presentation will be available at . 

About Teladoc Health 

Teladoc Health (NYSE: TDOC) is the global leader in virtual care. The company is delivering and orchestrating care across patients, care providers, platforms, and partners — transforming virtual care into a catalyst for how better health happens. Through our relationships with health plans, employers, providers, health systems and consumers, we are enabling more access, driving better outcomes, extending provider capacity and lowering costs. Learn more at . 

Investors: 

Michael Minchak 

  

617-444-9612 



EN
05/01/2026

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Teladoc Health Inc.

 PRESS RELEASE

Teladoc Health Launches Enhanced 24/7 Care Service

Teladoc Health Launches Enhanced 24/7 Care Service New capabilities enable Teladoc Health’s care teams to address a broader spectrum of health needs, delivering more value in virtual urgent care visits NEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the launch of new enhancements to its 24/7 Care service. The new capabilities build on the company’s flagship virtual urgent care service which provides access to licensed care providers who assess and treat non-emergency medical needs, 24 hours a day, seven days a ...

 PRESS RELEASE

Teladoc Health to Participate in Upcoming Investor Conference

Teladoc Health to Participate in Upcoming Investor Conference NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, announced today that Chuck Divita, chief executive officer, will participate in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 12, 2026, at 3:45 p.m. PT (6:45 p.m. ET). A live audio webcast and replay of the presentation will be available at .  About Teladoc Health Teladoc Health (NYSE: TDOC) is the global leader in virtual care. The company is delivering and orchestrating car...

 PRESS RELEASE

Teladoc Health to Participate in Upcoming Investor Conference

Teladoc Health to Participate in Upcoming Investor Conference NEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) --  (NYSE: TDOC), the global leader in virtual care, today announced that Chuck Divita, chief executive officer, will participate in the 37th Annual Piper Sandler Healthcare Conference in New York on Tuesday, December 2, 2025, at 12:30 p.m. ET. A live audio webcast and replay of the presentation will be available at . About Teladoc HealthTeladoc Health (NYSE: TDOC) is the global leader in virtual care. The company is delivering and orchestrating care across patients, care providers, pla...

Teladoc Health Inc: 1 director

A director at Teladoc Health Inc bought 10,000 shares at 6.940USD and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...

 PRESS RELEASE

Teladoc Health Announces Employee Inducement Award under NYSE Rule 303...

Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08 NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued an inducement award to a new employee. Effective November 1, 2025, in connection with commencing employment as Chief Technology Officer, Dave Ross was granted an award of restricted stock units covering 86,906 shares of Teladoc Health’s common stock, par value $0.001 per share (“Common Stock”), and an award of performance stock units covering a target of 86,906 shares of C...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch